Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
about
ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancersOverlapping nongenomic and genomic actions of thyroid hormone and steroidsInsulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant diseaseMet receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells17beta-estradiol induces the translocation of the estrogen receptors ESR1 and ESR2 to the cell membrane, MAPK3/1 phosphorylation and proliferation of cultured immature rat Sertoli cellsCytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth.Estrogen stimulation of cell migration involves multiple signaling pathway interactionsEstrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells.Novel actions of estrogen to promote proliferation: integration of cytoplasmic and nuclear pathways.MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.A signal transduction score flow algorithm for cyclic cellular pathway analysis, which combines transcriptome and ChIP-seq data.Progesterone receptor rapid signaling mediates serine 345 phosphorylation and tethering to specificity protein 1 transcription factors.Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models.Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor α signalling and results in tamoxifen insensitive proliferationTranslating extranuclear steroid receptor signaling to clinical medicine.Estrogen receptor-dependent genomic expression profiles in breast cancer cells in response to fatty acidsElevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression.LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways.Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.Tumorigenicity of MCF-7 human breast cancer cells lacking the p38α mitogen-activated protein kinaseRapid control of male typical behaviors by brain-derived estrogensLH-Induced Steroidogenesis in the Mouse Ovary, but Not Testis, Requires Matrix Metalloproteinase 2- and 9-Mediated Cleavage of Upregulated EGF Receptor LigandsGPER1-mediated IGFBP-1 induction modulates IGF-1-dependent signaling in tamoxifen-treated breast cancer cells.Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancerFocal adhesion kinase: a promising target for anticancer therapy.Estrogen promotes the survival and pulmonary metastasis of tuberin-null cells.Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2PDZK1 is a novel factor in breast cancer that is indirectly regulated by estrogen through IGF-1R and promotes estrogen-mediated growth.Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcomaMitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cellsEstrogen Regulation of MicroRNA ExpressionSignaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC.Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development.IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM moleculesProgestagen component in combined hormone replacement therapy in postmenopausal women and breast cancer risk: a debated clinical issue.Dual IGF-1R/InsR inhibitor BMS-754807 synergizes with hormonal agents in treatment of estrogen-dependent breast cancer.Insulin-like growth factor-I regulates GPER expression and function in cancer cells.Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis
P2860
Q24303562-AA23A373-B293-4511-93F3-604EE2E1C3F2Q26798025-CC3B3EA7-49F3-4AB4-9E66-1E0CF61A808BQ26800001-AE1AE165-B76A-4DC0-B62A-F08AE8A7298DQ27318931-5170C57D-461D-47C6-ADDC-0C7B0E575B73Q28581907-2097D222-6D3B-45F5-9679-173C24A03F7FQ30352693-4B04DCF6-179C-4AC0-95C7-B5DAAE9F6B7BQ30429931-360C4511-D0FC-4543-8FFF-5E31A3613FC1Q30433113-27230395-AAC4-44B0-BB0A-6A66AB7A5191Q30435726-63D0946F-F643-461B-9E1E-EA88E05FF4D0Q30495880-10DEA0B6-7DB4-4D2F-B2E2-6B4046AE6C89Q30572345-3295FF80-9E03-4B9D-9A9D-95E3857C56B4Q33315228-33C6C786-75E1-49AE-92F6-D817036B08EDQ33428469-65D5C200-2012-4765-8E22-93E0D916DA0AQ33612070-CA7A1ADF-26E9-4A28-B5A9-41D5D7D4F2A7Q33692847-A1DDD04A-D98B-4C8D-8EBC-C5280D44043DQ33747508-AF3F9818-61E0-447C-A453-00E7B7DF98FBQ33763973-C4735E54-C502-4F45-A43B-D67F5DE7EC5EQ34081759-25056E39-5DCC-40B7-8430-5485430A82F6Q35137643-1AE5F360-A609-44AD-8D09-7FF110A1F398Q35622899-13E73398-831D-4484-B463-B74817DAF523Q35622931-126B40DC-6AC5-4AB3-A713-EBA191FC37DBQ36392745-9FEFBD54-A837-4D34-A9F7-A886C3723353Q36455250-D11C0047-F8B2-454E-8610-DFADD6810C40Q36547331-E5FF5E8F-93C8-422E-81FF-4BB25200FA9AQ36568006-313DA39C-5DE5-4FE7-A37B-70834629FF60Q36956729-95AEDCAD-38EA-4188-8AC7-3B0F40F18C8EQ37087123-2959B167-F903-461C-8894-B5F67895A210Q37112684-2510AF8E-614C-4BE8-9E04-92CC2D9A170CQ37161525-BAC055C4-49B0-4C24-8D09-62F3006CAEDFQ37178458-F98E3C30-46F7-419E-AC60-EF90BAA21900Q37230675-505B9229-9249-44AE-BFC5-D7BDACAF44A1Q37250659-2632BEA9-0C7D-47A6-93A6-0E09FE240503Q37260036-ED20FE73-087A-4804-9FEE-57FEEC6AA7F1Q37467189-BB52406B-CC5F-4A77-A14C-68C31D38B5E4Q37581720-AAC1AD64-5971-4EC0-9A35-72AF4B64B56FQ37631072-35A063AF-66DD-4E3F-9C09-60E66489796FQ37731144-5D940D74-A3AC-46B8-885F-AEC7EAE99020Q39376878-34F057C2-8BA0-4596-BA2E-40D2BD1442A5Q39974866-AF474B13-C8E4-45CE-95E9-83B292393190Q41019747-A36C38BB-B0CF-4D07-8A29-4AACD4823110
P2860
Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Estrogen signaling via a linea ...... in MCF-7 breast cancer cells.
@ast
Estrogen signaling via a linea ...... in MCF-7 breast cancer cells.
@en
type
label
Estrogen signaling via a linea ...... in MCF-7 breast cancer cells.
@ast
Estrogen signaling via a linea ...... in MCF-7 breast cancer cells.
@en
prefLabel
Estrogen signaling via a linea ...... in MCF-7 breast cancer cells.
@ast
Estrogen signaling via a linea ...... in MCF-7 breast cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Estrogen signaling via a linea ...... in MCF-7 breast cancer cells.
@en
P2093
Richard J Santen
Robert X-D Song
Yongde Bao
Yucai Chen
Zhenguo Zhang
P2860
P304
P356
10.1210/EN.2007-0240
P407
P577
2007-05-24T00:00:00Z